Cue Biopharma, Inc (CUE) insider trading
Every open-market stock purchase and sale by Cue Biopharma, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Shao-Lee Lin (CEO) and 2 others sold $2M in the last 90 days.
- Last insider buy: Shao-Lee Lin (CEO), $1M, 4 months ago.
Last 12 months: insiders bought $1.6M (2 buys) and sold $2M (3 sales). Last close $28.16 on Aug 27, 2026.
Recent CUE insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Aug 13, 2026 | Shao-Lee Lin (CEO) | Sold | $308K |
| Aug 13, 2026 | Sumita Ray (Officer) | Sold | $196K |
| Aug 13, 2026 | Shao-Lee Lin (CEO) | Sold | $147K |
| Aug 13, 2026 | Michael Vincent Meluzio (VP) | Sold | $125K |
| Aug 13, 2026 | Sumita Ray (Officer) | Sold | $70K |
| Aug 13, 2026 | Shao-Lee Lin (CEO) | Sold | $66.8K |
| Aug 13, 2026 | Michael Vincent Meluzio (VP) | Sold | $44.6K |
| Aug 13, 2026 | Sumita Ray (Officer) | Sold | $125 |
| Aug 13, 2026 | Michael Vincent Meluzio (VP) | Sold | $93 |
| Aug 13, 2026 | Sumita Ray (Officer) | Bought (not open market) | — |
| Aug 13, 2026 | Michael Vincent Meluzio (VP) | Bought (not open market) | — |
| Aug 12, 2026 | Shao-Lee Lin (CEO) | Sold | $924K |
| Aug 12, 2026 | Shao-Lee Lin (CEO) | Sold | $160K |
| Aug 12, 2026 | Shao-Lee Lin (CEO) | Bought (not open market) | — |
| Jul 30, 2026 | James M Ahlers (CFO) | Bought (not open market) | — |
| Jul 30, 2026 | James M Ahlers (CFO) | Bought (not open market) | — |
| Jul 13, 2026 | Dominique Christian Borie (C-suite exec) | Bought (not open market) | — |
| Jul 13, 2026 | Dominique Christian Borie (C-suite exec) | Bought (not open market) | — |
| Jul 9, 2026 | Pamela Garzone (Insider) | Bought (not open market) | — |
| Jul 9, 2026 | Sumita Ray (Officer) | Bought (not open market) | — |
| Jul 9, 2026 | Pasha Sarraf (Insider) | Bought (not open market) | — |
| Jul 9, 2026 | Daniel A. Camardo (Insider) | Bought (not open market) | — |
| Jul 9, 2026 | Pamela Garzone (Insider) | Bought (not open market) | — |
| Jul 9, 2026 | Shao-Lee Lin (CEO) | Bought (not open market) | — |
| Jul 9, 2026 | Viola Mong Meehan (Insider) | Bought (not open market) | — |
Who's trading CUE
- Shao-Lee Lin, CEO: bought $1.5M (2 buys), sold $1.6M (5 sales), last Aug 13, 2026
- Sumita Ray, Officer: sold $266K (3 sales), last Aug 13, 2026
- Michael Vincent Meluzio, VP: sold $169K (3 sales), last Aug 13, 2026
- James M Ahlers, CFO: other filings, last Jul 30, 2026
- Dominique Christian Borie, C-suite exec: other filings, last Jul 13, 2026
- Daniel A. Camardo, Insider: other filings, last Jul 9, 2026
- Pasha Sarraf, Insider: bought $99.7K (5 buys), last Jul 9, 2026
- Viola Mong Meehan, Insider: other filings, last Jul 9, 2026
- Pamela Garzone, Insider: other filings, last Jul 9, 2026
- Lucinda Warren, C-suite exec: other filings, last Apr 9, 2026
- Daniel G. Baker, C-suite exec: other filings, last Apr 9, 2026
- Colin Sandercock, VP: other filings, last Apr 9, 2026
- Jill Marie Broadfoot, Insider: other filings, last Jan 2, 2026
- Patrick Verheyen, Insider: other filings, last Jan 2, 2026
- Peter A Kiener, Insider: other filings, last Jan 2, 2026
Get free alerts when an insider at Cue Biopharma, Inc files a new trade →